{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:02:04Z","timestamp":1789646524079,"version":"4.0.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:00:00Z","timestamp":1784764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Krystal Biotech"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11136-026-04322-9","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:11:19Z","timestamp":1784823079000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Eliciting health state utilities for open wounds in dystrophic epidermolysis bullosa"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1803-0764","authenticated-orcid":false,"given":"Damian","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5750-7772","authenticated-orcid":false,"given":"Adam B.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolijn","family":"van Keep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1738-8008","authenticated-orcid":false,"given":"Anna E.","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8113-0373","authenticated-orcid":false,"given":"Gabriela","family":"Petrof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagair","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharmila","family":"Nikapota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3147-861X","authenticated-orcid":false,"given":"Andria","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,23]]},"reference":[{"key":"4322_CR1","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.matbio.2022.04.007","volume":"110","author":"N Harvey","year":"2022","unstructured":"Harvey, N., Youssefian, L., Saeidian, A. H., Vahidnezhad, H., & Uitto, J. (2022). Pathomechanisms of epidermolysis bullosa: Beyond structural proteins. Matrix Biology, 110, 91\u2013105. https:\/\/doi.org\/10.1016\/j.matbio.2022.04.007","journal-title":"Matrix Biology"},{"issue":"5","key":"4322_CR2","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1111\/bjd.20958","volume":"186","author":"G Petrof","year":"2022","unstructured":"Petrof, G., Papanikolaou, M., Martinez, A. E., Mellerio, J. E., McGrath, J. A., Bardhan, A., Harper, N., Heagerty, A., Ogboli, M., & Chiswell, C. (2022). The epidemiology of epidermolysis bullosa in England and Wales: Data from the national epidermolysis bullosa database. British Journal of Dermatology, 186(5), 843\u2013848. https:\/\/doi.org\/10.1111\/bjd.20958","journal-title":"British Journal of Dermatology"},{"issue":"Supplement_1","key":"4322_CR3","doi-asserted-by":"publisher","first-page":"liaf085","DOI":"10.1093\/bjd\/ljaf085.086","volume":"193","author":"MM Kwiatkowska","year":"2025","unstructured":"Kwiatkowska, M. M., Hussain, S., Byrne, T., Fields, C., Moss, C., Bardhan, A., Rajan, N., Aston, J., Bethell, R., & Martin, D. (2025). SG10 (P058) The epidemiology of epidermolysis bullosa in England, 1997\u20132024: A retrospective national cohort study. British Journal of Dermatology, 193(Supplement_1), liaf085-519. https:\/\/doi.org\/10.1093\/bjd\/ljaf085.086","journal-title":"British Journal of Dermatology"},{"key":"4322_CR4","doi-asserted-by":"publisher","DOI":"10.2147\/tcrm.s386923","author":"P-C Hou","year":"2023","unstructured":"Hou, P.-C., Del Agua, N., Lwin, S. M., Hsu, C.-K., & McGrath, J. A. (2023). Innovations in the treatment of dystrophic epidermolysis bullosa (DEB): Current landscape and prospects. Therapeutics and Clinical Risk Management. https:\/\/doi.org\/10.2147\/tcrm.s386923","journal-title":"Therapeutics and Clinical Risk Management"},{"key":"4322_CR5","unstructured":"DEBRA UK. (2025). Dystrophic epidermolysis bullosa (DEB). from https:\/\/www.debra.org.uk\/get-support\/eb-support-and-resources\/about-eb-debra-uk\/dystrophic-epidermolysis-bullosa\/"},{"key":"4322_CR6","volume-title":"StatPearls [Internet]","author":"D Khanna","year":"2024","unstructured":"Khanna, D., & Bardhan, A. (2024). Epidermolysis Bullosa. StatPearls [Internet]. StatPearls Publishing."},{"key":"4322_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-021-01811-7","volume":"16","author":"JY Tang","year":"2021","unstructured":"Tang, J. Y., Marinkovich, M. P., Lucas, E., Gorell, E., Chiou, A., Lu, Y., Gillon, J., Patel, D., & Rudin, D. (2021). A systematic literature review of the disease burden in patients with recessive dystrophic epidermolysis bullosa. Orphanet Journal of Rare Diseases, 16, 1\u201325. https:\/\/doi.org\/10.1186\/s13023-021-01811-7","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"5","key":"4322_CR8","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jaad.2020.03.028","volume":"85","author":"VA Eng","year":"2021","unstructured":"Eng, V. A., Solis, D. C., Gorell, E. S., Choi, S., Nazaroff, J., Li, S., de Souza, M. P., Murrell, D. F., Marinkovich, M. P., & Tang, J. Y. (2021). Patient-reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: A global cross-sectional survey. Journal of the American Academy of Dermatology, 85(5), 1161\u20131167. https:\/\/doi.org\/10.1016\/j.jaad.2020.03.028","journal-title":"Journal of the American Academy of Dermatology"},{"key":"4322_CR9","doi-asserted-by":"publisher","DOI":"10.2147\/CWCMR.S97537","author":"E Rashidghamat","year":"2017","unstructured":"Rashidghamat, E., & Mellerio, J. E. (2017). Management of chronic wounds in patients with dystrophic epidermolysis bullosa: Challenges and solutions. Chronic Wound Care Management and Research. https:\/\/doi.org\/10.2147\/CWCMR.S97537","journal-title":"Chronic Wound Care Management and Research"},{"issue":"5","key":"4322_CR10","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.jaad.2020.08.118","volume":"85","author":"DC Solis","year":"2021","unstructured":"Solis, D. C., Teng, C., Gorell, E. S., Barriga, M., Nazaroff, J., Li, S., Lu, Y., Bruckner, A., Marinkovich, M. P., & Tang, J. Y. (2021). Classification of 2 distinct wound types in recessive dystrophic epidermolysis bullosa: A retrospective and cohort natural history study. Journal of the American Academy of Dermatology, 85(5), 1296\u20131298. https:\/\/doi.org\/10.1016\/j.jaad.2020.08.118","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"4322_CR11","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13023-023-02817-z","volume":"18","author":"JE Mellerio","year":"2023","unstructured":"Mellerio, J. E., Pillay, E. I., Ledwaba-Chapman, L., Bisquera, A., Robertson, S. J., Papanikolaou, M., McGrath, J. A., Wang, Y., Martinez, A. E., & Jeffs, E. (2023). Itch in recessive dystrophic epidermolysis bullosa: Findings of PEBLES, a prospective register study. Orphanet Journal of Rare Diseases, 18(1), 235. https:\/\/doi.org\/10.1186\/s13023-023-02817-z","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"4322_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-019-1279-y","volume":"15","author":"AL Bruckner","year":"2020","unstructured":"Bruckner, A. L., Losow, M., Wisk, J., Patel, N., Reha, A., Lagast, H., Gault, J., Gershkowitz, J., Kopelan, B., & Hund, M. (2020). The challenges of living with and managing epidermolysis bullosa: Insights from patients and caregivers. Orphanet journal of rare diseases, 15, 1\u201314. https:\/\/doi.org\/10.1186\/s13023-019-1279-y","journal-title":"Orphanet journal of rare diseases"},{"issue":"5","key":"4322_CR13","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1016\/j.jaad.2012.01.016","volume":"67","author":"E Pope","year":"2012","unstructured":"Pope, E., Lara-Corrales, I., Mellerio, J., Martinez, A., Schultz, G., Burrell, R., Goodman, L., Coutts, P., Wagner, J., & Allen, U. (2012). A consensus approach to wound care in epidermolysis bullosa. Journal of the American Academy of Dermatology, 67(5), 904\u2013917. https:\/\/doi.org\/10.1016\/j.jaad.2012.01.016","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"1","key":"4322_CR14","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13023-025-03635-1","volume":"20","author":"M El Hachem","year":"2025","unstructured":"El Hachem, M., Diociaiuti, A., Bonamonte, D., Brena, M., Lospalluti, L., Magnoni, C., Neri, I., Peris, K., Tadini, G., & Zambruno, G. (2025). Taking care of patients with recessive dystrophic epidermolysis bullosa from birth to adulthood: A multidisciplinary Italian Delphi consensus. Orphanet Journal of Rare Diseases, 20(1), 128. https:\/\/doi.org\/10.1186\/s13023-025-03635-1","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"7","key":"4322_CR15","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1007\/s11136-020-02495-5","volume":"29","author":"C Togo","year":"2020","unstructured":"Togo, C., Zidorio, A., Gon\u00e7alves, V., Hubbard, L., De Carvalho, K., & Dutra, E. (2020). Quality of life in people with epidermolysis bullosa: A systematic review. Quality of Life Research, 29(7), 1731\u20131745. https:\/\/doi.org\/10.1007\/s11136-020-02495-5","journal-title":"Quality of Life Research"},{"issue":"4","key":"4322_CR16","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2340\/00015555-1758","volume":"94","author":"WY Yuen","year":"2014","unstructured":"Yuen, W. Y., Frew, J. W., Veerman, K., van den Heuvel, E. R., Murrell, D. F., & Jonkman, M. F. (2014). Health-related quality of life in epidermolysis bullosa: Validation of the Dutch QOLEB questionnaire and assessment in the Dutch population. Acta Dermato-Venereologica, 94(4), 442\u2013447. https:\/\/doi.org\/10.2340\/00015555-1758","journal-title":"Acta Dermato-Venereologica"},{"issue":"2","key":"4322_CR17","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/pde.12262","volume":"31","author":"EA Eismann","year":"2014","unstructured":"Eismann, E. A., Lucky, A. W., & Cornwall, R. (2014). Hand function and quality of life in children with epidermolysis bullosa. Pediatric dermatology, 31(2), 176\u2013182. https:\/\/doi.org\/10.1111\/pde.12262","journal-title":"Pediatric dermatology"},{"issue":"1","key":"4322_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-017-0666-5","volume":"12","author":"J Brun","year":"2017","unstructured":"Brun, J., Chiaverini, C., Devos, C., Leclerc-Mercier, S., Mazereeuw, J., Bourrat, E., Maruani, A., Mallet, S., Abasq, C., & Phan, A. (2017). Pain and quality of life evaluation in patients with localized epidermolysis bullosa simplex. Orphanet journal of rare diseases, 12(1), 1\u20138. https:\/\/doi.org\/10.1186\/s13023-017-0666-5","journal-title":"Orphanet journal of rare diseases"},{"issue":"8","key":"4322_CR19","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1046\/j.1365-2230.2002.01121.x","volume":"27","author":"H Horn","year":"2002","unstructured":"Horn, H., & Tidman, M. (2002). Quality of life in epidermolysis bullosa. Clinical and Experimental Dermatology, 27(8), 707\u2013710. https:\/\/doi.org\/10.1046\/j.1365-2230.2002.01121.x","journal-title":"Clinical and Experimental Dermatology"},{"issue":"5","key":"4322_CR20","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/bjd.16350","volume":"178","author":"AL Bruckner","year":"2018","unstructured":"Bruckner, A. L., Fairclough, D. L., Feinstein, J. A., Lara-Corrales, I., Lucky, A. W., Tolar, J., & Pope, E. (2018). Reliability and validity of the instrument for scoring clinical outcomes of research for epidermolysis bullosa (iscor EB). British Journal of Dermatology, 178(5), 1128\u20131134. https:\/\/doi.org\/10.1111\/bjd.16350","journal-title":"British Journal of Dermatology"},{"issue":"24","key":"4322_CR21","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1056\/NEJMoa2206663","volume":"387","author":"SV Guide","year":"2022","unstructured":"Guide, S. V., Gonzalez, M. E., Ba\u011fc\u0131, I. S., Agostini, B., Chen, H., Feeney, G., Steimer, M., Kapadia, B., Sridhar, K., & Quesada Sanchez, L. (2022). Trial of beremagene geperpavec (B-VEC) for dystrophic epidermolysis bullosa. New England Journal of Medicine, 387(24), 2211\u20132219. https:\/\/doi.org\/10.1056\/NEJMoa2206663","journal-title":"New England Journal of Medicine"},{"key":"4322_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-019-3362-z","volume":"20","author":"JS Kern","year":"2019","unstructured":"Kern, J. S., Schwieger-Briel, A., L\u00f6we, S., Sumeray, M., Davis, C., & Martinez, A. E. (2019). Oleogel-S10 Phase 3 study \u201cEASE\u201d for epidermolysis bullosa: Study design and rationale. Trials, 20, 1\u201313. https:\/\/doi.org\/10.1186\/s13063-019-3362-z","journal-title":"Trials"},{"issue":"1","key":"4322_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0167-6296(86)90020-2","volume":"5","author":"GW Torrance","year":"1986","unstructured":"Torrance, G. W. (1986). Measurement of health state utilities for economic appraisal: A review. Journal of health economics, 5(1), 1\u201330. https:\/\/doi.org\/10.1016\/0167-6296(86)90020-2","journal-title":"Journal of health economics"},{"key":"4322_CR24","unstructured":"National Institute for Health and Care Excellence. (2025). NICE health technology evaluations: the manual from https:\/\/www.nice.org.uk\/process\/pmg36"},{"key":"4322_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10198-016-0783-4","volume":"17","author":"A Angelis","year":"2016","unstructured":"Angelis, A., Kanavos, P., L\u00f3pez-Bastida, J., Linertov\u00e1, R., Oliva-Moreno, J., Serrano-Aguilar, P., Posada-De-La-Paz, M., Taruscio, D., Schieppati, A., & Iskrov, G. (2016). Social\/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe. The European Journal of Health Economics, 17, 31\u201342. https:\/\/doi.org\/10.1007\/s10198-016-0783-4","journal-title":"The European Journal of Health Economics"},{"issue":"Suppl 1","key":"4322_CR26","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10198-016-0783-4","volume":"17","author":"A Angelis","year":"2016","unstructured":"Angelis, A., Kanavos, P., Lopez-Bastida, J., Linertova, R., Oliva-Moreno, J., Serrano-Aguilar, P., Posada-de-la-Paz, M., Taruscio, D., Schieppati, A., Iskrov, G., Brodszky, V., von der Schulenburg, J. M., Chevreul, K., Persson, U., Fattore, G., Network, B.-R. R. (2016). Social\/economic costs and health-related quality of life in patients with epidermolysis bullosa in Europe. European Journal of Health Economics, 17(Suppl 1), 31\u201342. https:\/\/doi.org\/10.1007\/s10198-016-0783-4","journal-title":"European Journal of Health Economics"},{"issue":"4","key":"4322_CR27","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1111\/j.1365-2133.2009.09306.x","volume":"161","author":"S Tabolli","year":"2009","unstructured":"Tabolli, S., Sampogna, F., Di Pietro, C., Paradisi, A., Uras, C., Zotti, P., Castiglia, D., Zambruno, G., & Abeni, D. (2009). Quality of life in patients with epidermolysis bullosa. British Journal of Dermatology, 161(4), 869\u2013877. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09306.x","journal-title":"British Journal of Dermatology"},{"issue":"6","key":"4322_CR28","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1111\/j.1365-2133.2009.09347.x","volume":"161","author":"J Frew","year":"2009","unstructured":"Frew, J., Martin, L., Nijsten, T., & Murrell, D. (2009). Quality of life evaluation in epidermolysis bullosa (EB) through the development of the QOLEB questionnaire: An EB-specific quality of life instrument. British Journal of Dermatology, 161(6), 1323\u20131330. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09347.x","journal-title":"British Journal of Dermatology"},{"issue":"5","key":"4322_CR29","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/pde.14802","volume":"38","author":"S Fulchand","year":"2021","unstructured":"Fulchand, S., Harris, N., Li, S., Barriga, M., Gorell, E., De Souza, M., Murrell, D., Marinkovich, M. P., Krishna Yenamandra, V., & Tang, J. Y. (2021). Patient-reported outcomes and quality of life in dominant dystrophic epidermolysis bullosa: A global cross-sectional survey. Pediatric Dermatology, 38(5), 1198\u20131201. https:\/\/doi.org\/10.1111\/pde.14802","journal-title":"Pediatric Dermatology"},{"issue":"5","key":"4322_CR30","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.jaad.2020.03.028","volume":"85","author":"A Victor","year":"2021","unstructured":"Victor, A., Solis, D. C., Gorell, E. S., Choi, S., Nazaroff, J., Li, S., de Souza, M. P., Murrell, D. F., Marinkovich, M. P., & Tang, J. Y. (2021). Patient-reported outcomes and quality of life in recessive dystrophic epidermolysis bullosa: A global cross-sectional survey. Journal of the American Academy of Dermatology, 85(5), 1161\u20131167. https:\/\/doi.org\/10.1016\/j.jaad.2020.03.028","journal-title":"Journal of the American Academy of Dermatology"},{"issue":"2","key":"4322_CR31","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.det.2011.11.003","volume":"30","author":"M-M Chren","year":"2012","unstructured":"Chren, M.-M. (2012). The Skindex instruments to measure the effects of skin disease on quality of life. Dermatologic Clinics, 30(2), 231\u2013236. https:\/\/doi.org\/10.1016\/j.det.2011.11.003","journal-title":"Dermatologic Clinics"},{"issue":"1","key":"4322_CR32","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5021\/ad.2016.28.1.6","volume":"28","author":"IK Jeon","year":"2016","unstructured":"Jeon, I. K., On, H. R., & Kim, S.-C. (2016). Quality of life and economic burden in recessive dystrophic epidermolysis bullosa. Annals of Dermatology, 28(1), 6\u201314. https:\/\/doi.org\/10.5021\/ad.2016.28.1.6","journal-title":"Annals of Dermatology"},{"issue":"3","key":"4322_CR33","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1111\/pde.14576","volume":"38","author":"DC Solis","year":"2021","unstructured":"Solis, D. C., Gorell, E. S., Teng, C., Barriga, M., Nazaroff, J., Li, S., Subica, A., Lu, Y., Marinkovich, M. P., & Tang, J. Y. (2021). Clinical characteristics associated with increased wound size in patients with recessive dystrophic epidermolysis bullosa. Pediatric Dermatology, 38(3), 704\u2013706. https:\/\/doi.org\/10.1111\/pde.14576","journal-title":"Pediatric Dermatology"},{"key":"4322_CR34","unstructured":"Wong-Baker Faces Foundation. (2023). Wong-Baker FACES Pain Rating Scale. from https:\/\/wongbakerfaces.org\/"},{"issue":"1","key":"4322_CR35","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1553-2712.2009.00620.x","volume":"17","author":"G Garra","year":"2010","unstructured":"Garra, G., Singer, A. J., Taira, B. R., Chohan, J., Cardoz, H., Chisena, E., & Thode, H. C., Jr. (2010). Validation of the Wong-Baker FACES pain rating scale in pediatric emergency department patients. Academic Emergency Medicine, 17(1), 50\u201354. https:\/\/doi.org\/10.1111\/j.1553-2712.2009.00620.x","journal-title":"Academic Emergency Medicine"},{"issue":"12","key":"4322_CR36","doi-asserted-by":"publisher","first-page":"507","DOI":"10.12968\/jpar.2021.13.12.507","volume":"13","author":"P Gangaram","year":"2021","unstructured":"Gangaram, P., Alinier, G., & Dippenaar, E. (2021). Paramedic adult pain assessment: Pilot study. Journal of Paramedic Practice, 13(12), 507\u2013513. https:\/\/doi.org\/10.12968\/jpar.2021.13.12.507","journal-title":"Journal of Paramedic Practice"},{"key":"4322_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12912-015-0094-6","volume":"14","author":"L Aziato","year":"2015","unstructured":"Aziato, L., Dedey, F., Marfo, K., Asamani, J. A., & Clegg-Lamptey, J. N. A. (2015). Validation of three pain scales among adult postoperative patients in Ghana. BMC Nursing, 14, 1\u20139. https:\/\/doi.org\/10.1186\/s12912-015-0094-6","journal-title":"BMC Nursing"},{"key":"4322_CR38","unstructured":"EuroQol Research Foundation. (2018). EQ-5D-3L User Guide. from https:\/\/euroqol.org\/information-and-support\/documentation\/user-guides"},{"key":"4322_CR39","unstructured":"EuroQol Research Foundation. (2024). EQ-5D-Y-3L User Guide. from https:\/\/euroqol.org\/information-and-support\/documentation\/user-guides\/"},{"issue":"11","key":"4322_CR40","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1097\/00005650-199711000-00002","volume":"35","author":"P Dolan","year":"1997","unstructured":"Dolan, P. (1997). Modeling valuations for EuroQol health states. Medical care, 35(11), 1095\u20131108. https:\/\/doi.org\/10.1097\/00005650-199711000-00002","journal-title":"Medical care"},{"issue":"2","key":"4322_CR41","first-page":"231","volume":"621","author":"R Rosenthal","year":"1994","unstructured":"Rosenthal, R., Cooper, H., & Hedges, L. (1994). Parametric measures of effect size. The Handbook of Research Synthesis, 621(2), 231\u2013244.","journal-title":"The Handbook of Research Synthesis"},{"issue":"1","key":"4322_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41687-021-00403-0","volume":"5","author":"AB Smith","year":"2021","unstructured":"Smith, A. B., Hanbury, A., & Buesch, K. (2021). Eliciting health state utilities for aromatic l-amino acid decarboxylase (AADC) deficiency: A UK vignette study. Journal of Patient-Reported Outcomes, 5(1), 1\u201310. https:\/\/doi.org\/10.1186\/s41687-021-00403-0","journal-title":"Journal of Patient-Reported Outcomes"},{"key":"4322_CR43","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2147\/PROM.S306228","volume":"12","author":"AB Smith","year":"2021","unstructured":"Smith, A. B., Hanbury, A., Ortiz, B., de Zarate, I., Hammes, F., de Pouvourville, G., & Buesch, K. (2021). Eliciting health state utilities for aromatic L-amino acid decarboxylase (AADC) deficiency: A vignette study in France. Patient Related Outcome Measures, 12, 237\u2013246. https:\/\/doi.org\/10.2147\/PROM.S306228","journal-title":"Patient Related Outcome Measures"},{"key":"4322_CR44","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1007\/s11136-017-1676-4","volume":"26","author":"S-H Kim","year":"2017","unstructured":"Kim, S.-H., Lee, S.-I., & Jo, M.-W. (2017). Feasibility, comparability, and reliability of the standard gamble compared with the rating scale and time trade-off techniques in Korean population. Quality of Life Research, 26, 3387\u20133397. https:\/\/doi.org\/10.1007\/s11136-017-1676-4","journal-title":"Quality of Life Research"},{"key":"4322_CR45","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12876-017-0660-3","volume":"17","author":"M Ock","year":"2017","unstructured":"Ock, M., Lim, S. Y., Lee, H.-J., Kim, S.-H., & Jo, M.-W. (2017). Estimation of utility weights for major liver diseases according to disease severity in Korea. BMC Gastroenterology, 17, 1\u20137. https:\/\/doi.org\/10.1186\/s12876-017-0660-3","journal-title":"BMC Gastroenterology"},{"key":"4322_CR46","unstructured":"M Hern\u00e1ndez Alava, S. P., A Wailoo. (2022). Estimating EQ-5D by age and sex for the UK. from https:\/\/sheffield.ac.uk\/nice-dsu\/methods-development\/estimating-eq-5d"},{"issue":"1","key":"4322_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13023-022-02419-1","volume":"17","author":"A Angelis","year":"2022","unstructured":"Angelis, A., Mellerio, J., & Kanavos, P. (2022). Understanding the socioeconomic costs of dystrophic epidermolysis bullosa in Europe: A costing and health-related quality of life study. Orphanet Journal of Rare Diseases, 17(1), 1\u201313.","journal-title":"Orphanet Journal of Rare Diseases"},{"key":"4322_CR48","unstructured":"DEBRA UK. (2023). EB Insights Study. from https:\/\/www.debra.org.uk\/get-involved\/members-participation\/eb-insights-study\/"},{"key":"4322_CR49","unstructured":"National Institute for Health and Care Excellence. (2023). Birch bark extract for treating epidermolysis bullosa from https:\/\/www.nice.org.uk\/guidance\/hst28"},{"key":"4322_CR50","unstructured":"Donna Rowen, J. B., Ruth Wong, Allan Wailoo. (2020). Measuring and valuing health-related quality of life when sufficient EQ-5D data is not available. from https:\/\/www.sheffield.ac.uk\/nice-dsu\/methods-development\/measuring-health-related-quality-life"},{"issue":"4","key":"4322_CR51","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s10880-010-9205-4","volume":"17","author":"F Margari","year":"2010","unstructured":"Margari, F., Lecce, P. A., Santamato, W., Ventura, P., Sportelli, N., Annicchiarico, G., & Bonifazi, E. (2010). Psychiatric symptoms and quality of life in patients affected by epidermolysis bullosa. Journal of clinical psychology in medical settings, 17(4), 333\u2013339. https:\/\/doi.org\/10.1007\/s10880-010-9205-4","journal-title":"Journal of clinical psychology in medical settings"},{"issue":"10","key":"4322_CR52","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/s40273-023-01300-8","volume":"41","author":"NJ Devlin","year":"2023","unstructured":"Devlin, N. J., Pan, T., Sculpher, M., Jit, M., Stolk, E., Rowen, D., van Hout, B., & Norman, R. (2023). Using age-specific values for pediatric HRQoL in cost-effectiveness analysis: Is there a problem to be solved? If so, how? PharmacoEconomics, 41(10), 1165\u20131174. https:\/\/doi.org\/10.1007\/s40273-023-01300-8","journal-title":"PharmacoEconomics"},{"issue":"1","key":"4322_CR53","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12955-022-01998-8","volume":"20","author":"N Devlin","year":"2022","unstructured":"Devlin, N., Pan, T., Kreimeier, S., Verstraete, J., Stolk, E., Rand, K., & Herdman, M. (2022). Valuing EQ-5D-Y: The current state of play. Health and Quality of Life Outcomes, 20(1), 105. https:\/\/doi.org\/10.1186\/s12955-022-01998-8","journal-title":"Health and Quality of Life Outcomes"}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04322-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11136-026-04322-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-026-04322-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:05:25Z","timestamp":1789643125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11136-026-04322-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,23]]},"references-count":53,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["4322"],"URL":"https:\/\/doi.org\/10.1007\/s11136-026-04322-9","relation":{},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,23]]},"assertion":[{"value":"16 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in accordance with the Declaration of Helsinki. This human study was approved by University of York Health Sciences Research Governance Committee (HSRGC\/2023\/556\/E). All parents, guardians or next of kin provided informed consent for the minors to participate in this study. All adult participants provided informed consent to participate in this study.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No identifying data were collected nor presented in the manuscript.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"237"}}